IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.453
EU - Europa 4.378
AS - Asia 861
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 8
AF - Africa 6
OC - Oceania 1
Totale 9.719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.426
IE - Irlanda 1.572
UA - Ucraina 788
GB - Regno Unito 613
CN - Cina 388
IT - Italia 342
DE - Germania 339
SE - Svezia 247
SG - Singapore 236
FI - Finlandia 207
TR - Turchia 174
GR - Grecia 154
FR - Francia 70
KR - Corea 38
BE - Belgio 17
CA - Canada 16
EU - Europa 12
MX - Messico 11
IN - India 7
NL - Olanda 7
RU - Federazione Russa 7
IR - Iran 6
SA - Arabia Saudita 4
AR - Argentina 3
CO - Colombia 3
ES - Italia 3
JP - Giappone 3
ET - Etiopia 2
PL - Polonia 2
BR - Brasile 1
BW - Botswana 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LI - Liechtenstein 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 9.719
Salva come PNG Salva come JPEG
Città #
Dublin 1.571
Jacksonville 1.197
Chandler 724
Princeton 243
Roxbury 195
New York 167
Ann Arbor 143
Cambridge 142
Singapore 138
Woodbridge 121
Boardman 117
Bremen 110
Wilmington 108
Medford 105
Beijing 59
San Mateo 55
Jinan 54
Ashburn 53
Des Moines 52
Mountain View 50
Nanjing 48
Düsseldorf 45
Shenyang 40
Seoul 38
Norwalk 28
Napoli 27
Caserta 25
Washington 20
Brussels 17
Helsinki 17
Zhengzhou 17
Changsha 16
Houston 15
Naples 15
Lanzhou 14
Marano Di Napoli 14
Ningbo 13
Haikou 12
Taizhou 12
Tianjin 12
Guangzhou 11
Hebei 11
Nanchang 11
Auburn Hills 10
Guadalupe 10
Rome 9
Bologna 8
Hangzhou 8
Los Angeles 8
Munich 8
Seattle 8
Venice 8
Volvera 8
Ottawa 7
Athens 6
Bari 6
Dearborn 6
Fairfield 6
Kunming 6
Latisana 6
Changchun 5
Taiyuan 5
Toronto 5
Zanjan 5
Elora 4
Groningen 4
Jiaxing 4
Menlo Park 4
Padova 4
Quarto 4
Rossano 4
Duncan 3
Hefei 3
Lappeenranta 3
Milan 3
Moscow 3
Orange 3
Perugia 3
Philadelphia 3
San Francisco 3
Torino 3
Addis Ababa 2
Amsterdam 2
Atripalda 2
Berlin 2
Boydton 2
Brindisi 2
Elice 2
Florence 2
Malo 2
Marano 2
Palermo 2
Pistoia 2
Pomigliano D'arco 2
Saint Paul 2
Salerno 2
Secaucus 2
Shanghai 2
Tokyo 2
Torre Del Greco 2
Totale 6.126
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 91
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 84
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 80
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 77
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 73
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 72
null 71
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 70
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 70
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 68
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 66
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 65
Chronic HCV infection and neurological and psychiatric disorders: an overview. 64
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 63
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 62
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 62
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 61
Decrease in HDV endemicity in Italy 60
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 60
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 60
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 59
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 59
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 59
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 59
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 58
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 58
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 58
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 57
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 57
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 56
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 56
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 56
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 56
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 55
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 55
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 55
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B 55
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 55
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 55
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 54
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 54
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 54
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 54
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 54
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 53
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 53
Interferon plus lamivudine treatment in young patients with chronic active B and C hepatitis 53
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 53
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 52
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 52
Mild chronic hepatitis C with steatosis: Which treatment? 52
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 52
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 51
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 51
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 51
Meningite batterica: epidemiologia e problematiche attuali di terapia. 51
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 51
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 51
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 50
HCV-related steatosis and risk of atherosclerosis 50
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 50
Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant 50
Treatment of chronic HBV infection in developing countries. 50
Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment 49
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays 49
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 49
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 49
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore 49
Comunicazione orale: Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 49
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 49
Hepatitis G virus/GBV-C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes 48
SEQUENTIAL ANALYSIS OF HEPATITIS B VIRUS CORE PROMOTER AND PRECORE REGIONS IN CANCER SURVIVOR PATIENTS WITH CHRONIC HEPATITIS B BEFORE, DURING AND AFTER INTERFERON TREATMENT 48
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 48
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 48
Infezioni respiratorie da Branhamella Catarralis in pazienti sottoposti a trapianto di cuore 48
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 48
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 48
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 48
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 48
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 48
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 47
Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene 47
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 47
First-phase HCV-RNA kinetic during antiviral therapy for chronic hepatitis C: clinical and virological correlates and predictive value for treatment outcome 47
Virological patterns of HCV patients with failure to interferon-free regimens. 47
Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection 46
Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection 46
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 46
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 46
Colestasi intraepatica in pazienti sottoposti a trapianto di cuore 46
Correlazione tra livelli di HCV-RNA nel siero, nel fegato e nei linfo-monociti del sangue periferico: possibile ruolo predittivo di risposta all'interferone. 46
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: An open-label, randomised controlled trial 46
Correlation between hepatitis C virus RNA levels in serum, liver, peripheral blood mononuclear cells and severity of liver disease in chronic hepatitis C patients. apitolo 27, pag. 244-250, 1996. 45
Comunicazione orale: Correlates and predictive value of early HCV-RNA kinetic during antiviral treatment 45
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 45
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 45
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici.Nostra esperienza negli ultimi 4 anni. 44
Mutants in HCV positive patients with hepatocellular carcinoma and occult HBV infection 44
Long-term outcome of HBV-HCV co-infection and HBV mono-infection acquired in youth 43
La combinazione interferone con N-acetilcisteina o interferone con ofloxacina non migliora la risposta in pazienti con epatite cronica C non-responders al solo interferone: studio di fase 1 43
Totale 5.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020857 0 214 12 6 202 24 245 34 53 22 38 7
2020/20211.780 128 4 192 105 412 7 227 183 13 233 202 74
2021/20221.446 58 13 4 14 482 19 26 44 63 149 110 464
2022/20232.945 261 50 33 228 339 227 10 168 1.486 25 56 62
2023/20241.182 94 28 41 72 421 181 34 36 6 13 88 168
2024/202552 8 44 0 0 0 0 0 0 0 0 0 0
Totale 10.132